首页> 外文OA文献 >OncoPaC-1: An Open-label, Single-Arm Pilot Study of Phosphorus-32 Microparticles Brachytherapy in Combination with Gemcitabine +/- Nab-Paclitaxel in Unresectable Locally Advanced Pancreatic Cancer

【2h】

OncoPaC-1: An Open-label, Single-Arm Pilot Study of Phosphorus-32 Microparticles Brachytherapy in Combination with Gemcitabine +/- Nab-Paclitaxel in Unresectable Locally Advanced Pancreatic Cancer

机译：Oncopac-1：一种开放式标签，单臂试验研究磷-32微粒近距离放射治疗与吉西他滨+/- Nab-PAClitaxel在不可切除的局部晚期胰腺癌中

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
M.S. Bhutani; J.B. Klapman; R. Tuli; G.E. El-Haddad; S. Hoffe; F.C.L. Wong; D.R. Fogelman; S. Lo; N.N. Nissen; A.E. Hendifar; G.R. Varadhachary; M.H. Katz; W.D. Erwin; E.P. Tamm; B.A.S. Singh; R. Mehta; A. Soman; A. Kraszewski; I.M. Cazacu; J.M. Herman;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. An open-label, single-arm pilot study of EUS-guided brachytherapy with phosphorus-32 microparticles in combination with gemcitabine plus /- nab-paclitaxel in unresectable locally advanced pancreatic cancer (OncoPaC-1): Technical details and study protocol [J] . Progress in Artificial Intelligence . 2020,第1期

机译：具有磷-32微粒的EUS引导的近距离放射治疗的开放式标签，与吉西滨加/ - 腹泻组合在不可切除的局部晚期胰腺癌中（ONCOPAC-1）：技术细节和研究方案
2. OncoPaC-1: An Open-label, Single-Arm Pilot Study of Phosphorus-32 Microparticles Brachytherapy in Combination with Gemcitabine plus /- Nab-Paclitaxel in Unresectable Locally Advanced Pancreatic Cancer [J] . Bhutani M. S., Klapman J. B., Tuli R., International Journal of Radiation Oncology, Biology, Physics . 2019,第1Suppla期

机译：Oncopac-1：一个开放标签，单臂试验研究磷-32微粒近距离放射治疗与Gemcitabine Plus / - Nab-Paclitaxel在不可切除的局部晚期胰腺癌中
3. Combination of gemcitabine, nab-paclitaxel, and S-1(GAS) as the first-line treatment for patients with locally advanced or advanced pancreatic ductal adenocarcinoma: study protocol for an open-label, single-arm phase I study [J] . Chen Chang, Xiaofen Li, Dan Cao BMC Cancer . 2021,第1期

机译：吉西他滨，NAB-PABLITAXEL和S-1（天然气）作为局部晚期或晚期胰腺导管腺癌患者的一线治疗：开放标签的研究方案，我研究的单臂阶段
4. A Pilot Study of Catheter-Based Ultrasound Hyperthermia with HDR Brachytherapy for Treatment of Locally Advanced Cancer of the Prostate and Cervix [C] . Chris J. Diederich, Jeff Wootton, Punit Prakash, International Symposium on Therapeutic Ultrasound (2002-) . 2011

机译：基于HDR近距离放射治疗治疗前列腺和子宫颈局部晚期癌症的导管超声热疗试验研究
5. Multiscale Pharmacodynamic Studies of Combination Gemcitabine and Trabectedin for the Treatment of Pancreatic Cancer. [D] . Miao, Xin. 2017

机译：吉西他滨联合曲贝汀联合治疗胰腺癌的多尺度药效学研究。
6. An open-label single-arm pilot study of EUS-guided brachytherapy with phosphorus-32 microparticles in combination with gemcitabine +/- nab-paclitaxel in unresectable locally advanced pancreatic cancer (OncoPaC-1): Technical details and study protocol [O] . Manoop S. Bhutani, Jason B. Klapman, Richard Tuli, 2020

机译：EUS指导的磷32微粒联合吉西他滨+/- nab-紫杉醇联合EUS引导的近距离放射治疗在无法切除的局部晚期胰腺癌（OncoPaC-1）中的开放标签单臂试验研究：技术细节和研究方案
7. Study protocol for an open-label, single-arm, phase Ib/II study of combination of toripalimab, nab-paclitaxel, and gemcitabine as the first-line treatment for patients with unresectable pancreatic ductal adenocarcinoma [O] . Lin Shui, Ke Cheng, Xiaofen Li, 2020

机译：用于开放标签，单臂，相IB / II的研究方案，替代素蛋白，NAB-PABLITAXEL和GEMCITABINE的组合作为不可切除的胰腺导管腺癌患者的一线治疗

OncoPaC-1: An Open-label, Single-Arm Pilot Study of Phosphorus-32 Microparticles Brachytherapy in Combination with Gemcitabine +/- Nab-Paclitaxel in Unresectable Locally Advanced Pancreatic Cancer

著录项

相似文献

相关主题

期刊订阅